TARC Ltd's financial performance shows significant weaknesses. Sales Growth is sharply declining, with a TTM of -70% and a 3-year Compounded Sales Growth of -49%. The operating profit margin (OPM) is also concerning, with a latest quarterly OPM of -708% (Mar 2025) and an annual OPM of -395% (Mar 2025). Net Profit is also negative, with a -231 Cr loss reported for Mar 2025. These figures indicate serious challenges in revenue generation and cost management.

The capital efficiency and returns for TARC Ltd are weak. The Return on Capital Employed (ROCE) has been fluctuating and is currently negative at -5% (Mar 2025). Similarly, the Return on Equity (ROE) is also negative at -20% (Last Year). These negative returns indicate that the company is struggling to generate profits from its capital and equity. The negative ROCE and ROE raise concerns about the company's ability to create value for its investors.

TARC Ltd's financial health presents mixed signals. The company's borrowings have increased to ₹ 1,954 Cr. as of March 2025. While the company has not been paying dividends, which could be seen as a measure to conserve cash, the increasing debt levels are a concern. The increasing borrowings could strain the company's financials, especially if profitability does not improve.

TARC Ltd's operational efficiency shows significant weaknesses. The Working Capital Days have increased dramatically to 10,883 days in March 2025. This substantial increase indicates severe challenges in managing working capital, potentially due to slow inventory turnover or delayed receivables. The Cash Conversion Cycle has also increased to 16,017 days in March 2025, further confirming operational inefficiencies.

TARC Ltd has some off-balance sheet exposures primarily through other liabilities. These liabilities have shown an increasing trend, reaching ₹1,219 Cr. in March 2025. Monitoring these liabilities is crucial to assessing the company's overall financial risk.

There is no specific data available on contingent liabilities in the provided data.

The sharp fluctuations in material costs as a percentage of sales, such as the spikes in Mar 2022 (1,255%) and Mar 2025 (274%), warrant further scrutiny to ensure accurate cost reporting.